Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138135 · ClinicalTrials.gov registry record · NA
HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing
A NA study, sponsored by Public Health Foundation Enterprises.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT03138135: Completed NA study, sponsored by Public Health Foundation Enterprises.
NCT03138135 is a NA study that has completed, run by Public Health Foundation Enterprises. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03138135, a NA study, has completed, sponsored by Public Health Foundation Enterprises.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with Men (MSM) use these new testing options, a set of online support tools, and the option to test with someone to support them (a testing "buddy"). We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.
Primary Outcome
Between-arm differences in initiation of PrEP; qualitative evaluation of linkage to HIV care.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL HOME Study intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2017-01-09 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
What the finished NCT03138135 record still lists
NCT03138135 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03138135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03138135 about?
NCT03138135 is a clinical study titled "HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing". Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with M...
What is the current status of trial NCT03138135?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2017-01-09. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03138135?
The interventions under investigation include: Control (BEHAVIORAL), HOME Study intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03138135?
This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03138135's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI